4 ms·
https://www.nytimes.com/2021/03/21/world/vaccine-patents-us-eu.html https://www.nytimes.com/2021/03/21/world/vaccine-patents-us-... Apparently it’s not as simp
by tmslnz 5y ago
https://www.nytimes.com/2021/03/21/world/vaccine-patents-us-eu.html https://www.nytimes.com/2021/03/21/world/vaccine-patents-us-...
Apparently it’s not as simple as temporarily waiving IP claims. On the one hand they don’t even own some of the rights being waived, and on the other hand they would need to do more than just waiving rights to truly support their stated goal of accelerating immunisation against COVID-19.
This leaves, for me, a weird taste of a PR exercise more than a true commitment to the message they sent out.
- behnamoh 5y agoWhat more do you expect from them? The bottleneck - as other comments mentioned - is the supply chain.
- tmslnz 5y agoI’d expect them to give something closer to the equivalent of a recipe than just a “list of ingredients”, as other comments have highlighted too in this thread. If you ask me how to bake a cake and I just tell you “butter, eggs and cumin” that’s not quite the same as also giving you the timings, measurements, cooking temp, etc.